15467-31-9

Basic information

• Product Name: 2-(1H-indol-3-yl)-2-methylpropan-1-amine
• Synonyms: 2-(1H-indol-3-yl)-2-methylpropan-1-amine;1H-Indole-3-ethanaMine, b,b-diMethyl-;3-(2-Amino-tert-butyl)indole;beta,beta-Dimethyltryptamine
• CAS NO: 15467-31-9
• Molecular Formula: C₁₂H₁₆N₂
• Molecular Weight: 188.272
• Mol File: 15467-31-9.mol

Chemical Properties

• Boiling Point: 347.3°Cat760mmHg
• Flash Point: 190.7°C
• Appearance: /
• Density: 1.093
• Vapor Pressure: 5.45E-05mmHg at 25°C
• Refractive Index: 1.619
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 2-(1H-indol-3-yl)-2-methylpropan-1-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1H-indol-3-yl)-2-methylpropan-1-amine(15467-31-9)
• EPA Substance Registry System: 2-(1H-indol-3-yl)-2-methylpropan-1-amine(15467-31-9)

Safety Data

• Hazardous Substances Data: 15467-31-9(Hazardous Substances Data)

Usage

Uses

Used in Recreational Drug Use:
2-(1H-indol-3-yl)-2-methylpropan-1-amine is used as a psychoactive substance for its euphoric and hallucinogenic effects, providing users with experiences similar to those induced by amphetamine and LSD.
Used in Research and Development:
Although not explicitly mentioned in the provided materials, 2-(1H-indol-3-yl)-2-methylpropan-1-amine may be utilized in scientific research for understanding the mechanisms of action of psychoactive substances and developing potential therapeutic agents. However, this application is subject to strict regulations and ethical considerations due to the drug's controlled status and potential for abuse.

InChI:InChI=1/C12H16N2/c1-12(2,8-13)10-7-14-11-6-4-3-5-9(10)11/h3-7,14H,8,13H2,1-2H3

Upstream product

• 2770-92-5 2-indol-3-yl-2-methyl-propionic acid 
• 380626-46-0 3-(2-cyanopropane-2-yl)-1H-indol-1-carboxylic acid tert-butyl ester 
• 23078-29-7 2-(1H-indol-3-yl)-2-methylpropanenitrile 

Downstream Products

• 942145-77-9 isopropyl 1,1-dimethyl-1,2,3,6-tetrahydro-azepino[4,5-b]indole-5-carboxylate 
• 629662-20-0 ethyl 1,1-dimethyl-1,2,3,6-tetrahydro-azepino[4,5-b]indole-5-carboxylate 

Relevant articles and documents

Benzylamine derivatives and its application on the medicament

The invention provides novel benzylamine derivatives or stereoisomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or pro-drugs thereof for treating Alzheimer diseases. The invention also provides a medicine composition containing a compound provided by the invention and a method for treating the Alzheimer diseases by using the compound or the medicine composition of the compound provided by the invention.

Substituted heterocyclic compound and its application on the medicament

The invention provides a novel substituted heterocyclic compound or stereisomers, stereomers, tautomers, oxynitrides, hydrates, solvates, metabolites, and pharmaceutically acceptable salts or prodrugs thereof. The novel substituted heterocyclic compound i

Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)

Azepino[4,5-b]indoles have been identified as potent agonists of the farnesoid X receptor (FXR). In vitro and in vivo optimization has led to the discovery of 6m (XL335, WAY-362450) as a potent, selective, and orally bioavailable FXR agonist (EC50 = 4 nM, Eff = 149%). Oral administration of 6m to LDLR-/- mice results in lowering of cholesterol and triglycerides. Chronic administration in an atherosclerosis model results in significant reduction in aortic arch lesions.

NOVEL TRICYCLIC HETEROCYCLE COMPOUND

―The present invention relates to the compound represented by formula (I) ????????A―X―Y―Z―B?????(I) (wherein A is a cyclic group which may have a substituent(s); X is a single bond or a spacer; Y is a single bond or a spacer; Z is a single bond or a spacer; B is a hydrocarbon group which may have a substituent(s) or a cyclic group which may have a substituent(s)), a salt thereof, a solvate thereof or a prodrug thereof. The compound represented by formula (I), a salt thereof, a solvate thereof or a prodrug thereof is useful for preventive and/or therapeutic agent for a disease caused by stress.

-3 (SULFONAMIDOETHYL) -INDOLE DERIVATIES FOR USE AS GLUCOCORTICOID MIMETICS IN THE TREATMENT OF INFLAMMATORY, ALLERGIC AND PROLIFERATIVE DISEASES

Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Y are as defined herein, or a tautomer, prodrug, solvate, or sal